OS5.2 Health-Related Quality of Life (HRQoL) in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only (randomized phase III EORTC study 26101).
| Image |  |
|---|---|
| Description | scientific article published on 21 September 2016 |
| Author/s |
author: Wolfgang Wick |
| Publication date | September 21, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |